Open AccessTreatment of Hypertension Among A frican A mericans: The J ackson Heart Study
Author(s) -
Harman Jane,
Walker Evelyn R.,
Charbonneau Vicki,
Akylbekova Ermeg L.,
Nelson Cheryl,
Wyatt Sharon B.
Publication year - 2013
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.12088
Subject(s) - thiazide , blood pressure , medicine , diabetes mellitus , calcium channel blocker , kidney disease , urology , endocrinology
Hypertension treatment regimens used by A frican A merican adults in the J ackson H eart S tudy were evaluated at the first two clinical examinations (2415 treated hypertensive persons at e xamination I [exam I] , 2000–2004; 2577 at e xamination II [exam II] , 2005–2008). Blood pressure ( BP ) was below 140/90 mm Hg for 66% and 70% of treated participants at e xam I and e xam II , respectively. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure treatment targets were met for 56% and 61% at e xam I and e xam II , respectively. Persons with diabetes or chronic kidney disease were less likely to have BP at target, as were men compared with women. Thiazide diuretics were the most commonly used antihypertensive medication, and persons taking a thiazide were more likely to have their BP controlled than persons not taking them; thiazides were used significantly less among men than women. Although calcium channel blockers are often considered to be effective monotherapy for A frican A mericans, persons using calcium channel blocker monotherapy were significantly less likely to be at target BP than persons using thiazide monotherapy.